Drug Protects Mice from Heart Failure Post-Heart Attack
Cedars-Sinai investigators identify a potential way to avert heart failure for survivors of heart attacks.
Cedars-Sinai investigators identify a potential way to avert heart failure for survivors of heart attacks.
Researchers have developed an optimized electrophysiological model showing that heart defibrillation can be achieved with much lower energy than current methods used.
By genetically manipulating cells to revert to a fetal-like state, scientists triggered the regeneration of heart muscle in adult mice.
Read MoreA small, implantable cardiac pump called the Jarvik 2015 ventricular assist device has shown promising results in a feasibility trial in kids.
Read MoreA multicenter study finds that a drug initially approved for type 2 diabetes benefits patients after admission to the hospital for acute heart failure.
Read MoreInter-atrial shunts may be beneficial to heart failure patients with reduced left ventricular ejection fraction (LVEF) but harmful or even deadly for heart failure patients with preserved LVEF, a new Mount Sinai-led study shows.
Read MoreA study by UT Southwestern Medical Center has demonstrated that a combination of FDA-approved drugs can effectively regenerate damaged heart muscle.
Read MoreA beta blocker typically used to treat heart problems, hemangioma, migraines, and anxiety could be a new therapeutic for patients with sickle cell disease.
Read MoreWomen with atrial fibrillation undergoing a procedure called pulsed field ablation have just as good outcomes as men, a new study finds.
Read MoreThe US Food and Drug Administration approved Medtronic’s Aurora EV-ICD MRI SureScan and Epsila EV MRI SureScan defibrillation lead to treat dangerously fast heart rhythms that can lead to sudden cardiac arrest.
Read MoreAged black garlic supplementation reduced blood pressure in a grade I hypertensive patients already taking blood-pressure reducing medications.
Read More